[Is non-allergenic bronchial hyperreactivity a good diagnostic test for asthma?]

Area of Science:

• Pulmonology
• Respiratory Medicine
• Clinical Diagnostics

Background:

• Non-allergic bronchial hyperreactivity (NBH) is a potential, but not definitive, indicator in asthma diagnosis.
• Current diagnostic approaches for asthma may be limited by the information provided by NBH testing.
• Understanding the utility of NBH testing across different populations and disease severities is crucial.

Purpose of the Study:

• To evaluate the diagnostic utility of non-allergic bronchial hyperreactivity measurement for asthma.
• To assess the sensitivity, specificity, and predictive values of NBH testing in various clinical scenarios.
• To determine the limitations of NBH testing in epidemiological studies and individual patient diagnosis.

Main Methods:

• Analysis of sensitivity and specificity data for NBH testing in the general population.
• Evaluation of positive and negative predictive values in relation to varying asthma prevalence.
• Consideration of spectrum bias and differential diagnosis challenges in individual patient assessment.

Main Results:

• NBH testing shows a sensitivity of 46% and specificity of 89% in the general population.
• Positive and negative predictive values are of limited use when asthma prevalence is low (1-10%).
• Test characteristics can vary with disease severity, and other conditions can also cause bronchial hyperreactivity.

Conclusions:

• Non-allergic bronchial hyperreactivity measurement provides limited information for asthma diagnosis in epidemiological and individual contexts.
• The predictive values of NBH testing are insufficient for reliable diagnosis, particularly in low-prevalence populations.
• NBH testing is most informative only when asthma diagnosis is already highly probable or certain.